Request Appointment
177 Fort Washington AveNew York, NY 10032
Fax+1 212-305-1754
Overview of Dr. Zucker
Dr. Jason Zucker is an infectious disease specialist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Allen Hospital. He received his medical degree from Rutgers New Jersey Medical School and has been in practice 9 years. He is one of 133 doctors at New York-Presbyterian Hospital and one of 45 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Infectious Disease. He has more than 100 publications and over 500 citings.
Education & Training
Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine/Pediatrics, 2010 - 2014- Rutgers New Jersey Medical SchoolClass of 2010
Certifications & Licensure
NY State Medical License 2015 - 2026
NJ State Medical License 2014 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): a...Chloe Orkin, Amy Paterson, Alexa Elias, Melanie Smuk, Kyle Ring
The Lancet. HIV. 2025-08-04 - Hospital wastewater surveillance for SARS-CoV-2 identifies intra-hospital dynamics of viral transmission and evolution.Medini K Annavajhala, Anne L Kelley, Lingsheng Wen, Maya Tagliavia, Sofia Z Moscovitz
Applied and Environmental Microbiology. 2025-07-23 - A call to move beyond MSM-centric framing in mpox research.Camila H Coelho, Rory D de Vries, Carolina Lucas, Jason Zucker
The Lancet. Infectious Diseases. 2025-07-15
Press Mentions
High Viral Load Spikes Placental MalariaJuly 24th, 2025- There’s Finally a New Treatment for Drug-Resistant GonorrheaApril 18th, 2025
- Newly FDA-Approved Antibiotic Gepotidacin May Effectively Treat GonorrheaApril 15th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
